515 related articles for article (PubMed ID: 30669679)
1. Nicotinamide Mononucleotide: Exploration of Diverse Therapeutic Applications of a Potential Molecule.
Poddar SK; Sifat AE; Haque S; Nahid NA; Chowdhury S; Mehedi I
Biomolecules; 2019 Jan; 9(1):. PubMed ID: 30669679
[TBL] [Abstract][Full Text] [Related]
2. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside salvage pathway for NAD biosynthesis in Salmonella typhimurium.
Liu G; Foster J; Manlapaz-Ramos P; Olivera BM
J Bacteriol; 1982 Dec; 152(3):1111-6. PubMed ID: 6216244
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
5. Engineering Escherichia coli Nicotinic Acid Mononucleotide Adenylyltransferase for Fully Active Amidated NAD Biosynthesis.
Wang X; Zhou YJ; Wang L; Liu W; Liu Y; Peng C; Zhao ZK
Appl Environ Microbiol; 2017 Jul; 83(13):. PubMed ID: 28455340
[TBL] [Abstract][Full Text] [Related]
6. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.
Soma M; Lalam SK
Mol Biol Rep; 2022 Oct; 49(10):9737-9748. PubMed ID: 35441939
[TBL] [Abstract][Full Text] [Related]
7. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health.
Alegre GFS; Pastore GM
Curr Nutr Rep; 2023 Sep; 12(3):445-464. PubMed ID: 37273100
[TBL] [Abstract][Full Text] [Related]
8. Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
Yamamoto T; Byun J; Zhai P; Ikeda Y; Oka S; Sadoshima J
PLoS One; 2014; 9(6):e98972. PubMed ID: 24905194
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of long-term nicotinamide mononucleotide supplementation on metabolism, sleep, and nicotinamide adenine dinucleotide biosynthesis in healthy, middle-aged Japanese men.
Yamaguchi S; Irie J; Mitsuishi M; Uchino Y; Nakaya H; Takemura R; Inagaki E; Kosugi S; Okano H; Yasui M; Tsubota K; Hayashi K; Yoshino J; Itoh H
Endocr J; 2024 Feb; 71(2):153-169. PubMed ID: 38191197
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide mononucleotide inhibits JNK activation to reverse Alzheimer disease.
Yao Z; Yang W; Gao Z; Jia P
Neurosci Lett; 2017 Apr; 647():133-140. PubMed ID: 28330719
[TBL] [Abstract][Full Text] [Related]
11. Technology and functional insights into the nicotinamide mononucleotide for human health.
Liu Y; Gong JS; Marshall G; Su C; Shi JS; Xu ZH
Appl Microbiol Biotechnol; 2023 Aug; 107(15):4759-4775. PubMed ID: 37347262
[TBL] [Abstract][Full Text] [Related]
12. Effect of nicotinamide mononucleotide on brain mitochondrial respiratory deficits in an Alzheimer's disease-relevant murine model.
Long AN; Owens K; Schlappal AE; Kristian T; Fishman PS; Schuh RA
BMC Neurol; 2015 Mar; 15():19. PubMed ID: 25884176
[TBL] [Abstract][Full Text] [Related]
13. NAD
Yoshino J; Baur JA; Imai SI
Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689
[TBL] [Abstract][Full Text] [Related]
14. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.
Ratajczak J; Joffraud M; Trammell SA; Ras R; Canela N; Boutant M; Kulkarni SS; Rodrigues M; Redpath P; Migaud ME; Auwerx J; Yanes O; Brenner C; Cantó C
Nat Commun; 2016 Oct; 7():13103. PubMed ID: 27725675
[TBL] [Abstract][Full Text] [Related]
15. [Aging and homeostasis. Age-associated diseases and clinical application of NMN(Nicotinamide Mononucleotide).].
Irie J; Itoh H
Clin Calcium; 2017; 27(7):983-990. PubMed ID: 28649105
[TBL] [Abstract][Full Text] [Related]
16. Hydroxyapatite-based nano-drug delivery system for nicotinamide mononucleotide (NMN): significantly enhancing NMN bioavailability and replenishing in vivo nicotinamide adenine dinucleotide (NAD+) levels.
Zhang D; Yau LF; Bai LB; Tong TT; Cao KY; Yan TM; Zeng L; Jiang ZH
J Pharm Pharmacol; 2023 Dec; 75(12):1569-1580. PubMed ID: 37862582
[TBL] [Abstract][Full Text] [Related]
17. Detection and pharmacological modulation of nicotinamide mononucleotide (NMN) in vitro and in vivo.
Formentini L; Moroni F; Chiarugi A
Biochem Pharmacol; 2009 May; 77(10):1612-20. PubMed ID: 19426698
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical evidence of NAD
Reiten OK; Wilvang MA; Mitchell SJ; Hu Z; Fang EF
Mech Ageing Dev; 2021 Oct; 199():111567. PubMed ID: 34517020
[TBL] [Abstract][Full Text] [Related]
19. [Advances in physiological activities and synthesis of β-nicotinamide mononucleotide].
Chen Y; Zhou C; Huang J; Tao Y; Ke C; Yang X
Sheng Wu Gong Cheng Xue Bao; 2023 Feb; 39(2):516-536. PubMed ID: 36847087
[TBL] [Abstract][Full Text] [Related]
20. Host-microbiome interactions in nicotinamide mononucleotide (NMN) deamidation.
Kim LJ; Chalmers TJ; Madawala R; Smith GC; Li C; Das A; Poon EWK; Wang J; Tucker SP; Sinclair DA; Quek LE; Wu LE
FEBS Lett; 2023 Sep; 597(17):2196-2220. PubMed ID: 37463842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
